Real-World Analysis Highlighting HAE Disease Experience and Gaps in Treatment Satisfaction Published in Advances in Therapy

Impact · against what's priced in

The real-world analysis supports the commercial value proposition for Pharvaris's oral B2 receptor antagonists by quantifying patient preference for oral delivery over injectables. This data strengthens the thesis for higher peak sales and better patient adherence compared to existing injectable prophylaxis.

PHVS+0.40

No priced-in read yet